We are live on ! Find out more
DOFI

DCVC Opportunity Fund II Portfolio holdings

AUM $13.9M
1-Year Est. Return 8.04%
This Fund
S&P 500
This Quarter Est. Return
-3.56%
1 Year Est. Return
+8.04%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3M
AUM Growth
-$96M
Cap. Flow
-$95.3M
Cap. Flow %
-494.05%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RKLB icon
Rocket Lab Corp
RKLB
+$95.3M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
2 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXRX icon
1
Recursion Pharmaceuticals
RXRX
$1.57B
$19.3M 100%
3,951,141
RKLB icon
2
Rocket Lab Corp
RKLB
$39.9B
-2,663,139
Closed -$95.3M

Similar funds

DCVC Opportunity Fund II's Q3 2025 Portfolio in Review

As of Q3 2025, DCVC Opportunity Fund II held 2 positions worth $19.3M, down 83% from $115M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

DCVC Opportunity Fund II withdrew a net $95.3M in Q3 2025, closing 1 position. Its most notable exit was Rocket Lab Corp, an estimated $95.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 17% a quarter earlier, followed by Industrials.

  • DCVC Opportunity Fund II fully exited Rocket Lab Corp in Q3 2025, selling an estimated $95.3M.
  • DCVC Opportunity Fund II's ten largest holdings make up 100% of its $19.3M portfolio in Q3 2025.
  • DCVC Opportunity Fund II opened 0 new positions and closed 1 in Q3 2025.
  • DCVC Opportunity Fund II's portfolio value fell 83% quarter-over-quarter to $19.3M.

Based on DCVC Opportunity Fund II's 13F filing for Q3 2025, filed 14 Nov 2025.